CA30668-1A - 0x0000000000004A35

Healthy Males & Females

Anti

* Stipend may pay up to reflected amount.

Study Details

Study Number: CA30668
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 1,375

Study Criteria

Age: 18 - 0
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat non-cystic fibrosis bronchiectasis.
Route of Administration: Inhalation
Blood Draws: 10

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 3 Night Stay & 2 Returns

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
No search results